SCHEMBL8870517

SCHEMBL8870517

CCOCCNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NCCc3ccc(Cl)cc3)cc2)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 2/20 0.50
EGFR P00533 1/20 0.50
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
FLT1 P17948 1/20 0.46
FLT4 P35916 1/20 0.46
KDR P35968 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPT P10636 2/20 0.45
CYP1A2 P05177 1/20 0.45
GAA P10253 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C19 P33261 1/20 0.45
GFER P55789 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
BCL2L1 Q07817 1/20 0.45
MCL1 Q07820 1/20 0.45
NAMPT P43490 1/20 0.45
P4HTM Q9NXG6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8867904 0.92 MAPT (0.51) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL8868930 0.92 P4HTM (0.51) PPARANPC1RAB9AMEN1KMT2A
SCHEMBL8869577 0.92 EGFR (0.53) PPARAEGFRNPC1RAB9AFLT1
SCHEMBL8869604 0.92 EGFR (0.53) PPARAEGFRNPC1RAB9AFLT1
SCHEMBL8868626 0.91 P4HTM (0.57) PPARANPC1RAB9AMEN1KMT2A
SCHEMBL8869631 0.91 P4HTM (0.53) EGFRNPC1RAB9AFLT1FLT4
SCHEMBL7862718 0.90 EGFR (0.49) PPARAEGFRNPC1RAB9AFLT1
SCHEMBL8869128 0.89 PPARA (0.50) PPARAEGFRNPC1RAB9AFLT1
SCHEMBL9140566 0.88 EGFR (0.51) PPARAEGFRNPC1RAB9AFLT1
SCHEMBL9140521 0.88 EGFR (0.51) PPARAEGFRNPC1RAB9AFLT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed